Supply Disruption Alert: Phenytoin (Epanutin®) 30mg/5ml Oral Suspension (Pfizer)

Supply Disruption Alert: Phenytoin (Epanutin®) 30mg/5ml Oral Suspension (Pfizer)

February 25, 2020

Department of Health and Social Care (DHSC) has issued a medicine supply disruption alert for Phenytoin (Epanutin®) 30mg/5ml Oral Suspension (Pfizer).

Pfizer have limited supplies of Phenytoin (Epanutin®) 30mg/5ml Oral Suspension and anticipate going out of stock w/c 2nd March 2020. The anticipated re-supply date is late June 2020.

The Canadian brand of Phenytoin 30mg/5ml oral suspension – ‘Dilantin-30®’ (imported equivalent to Epanutin® 30mg/5ml oral suspension) is available from specialist importers on an ‘unlicensed’ basis.

There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems. Where a prescriber wishes to prescribe an unlicensed import, a paper prescription should be issued as ‘Phenytoin 30mg/5ml Oral Suspension (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special with the following:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.



Posted in: ,


More Latest News >

Funding for Easter opening hours

Further to NHS England and NHS Improvement’s (NHSE&I) decision that community pharmacies in England must open between 2pm and 5pm...